Hydrogen‐rich saline reducing cardiac toxicity induced by adriamycin in rats (850.6)
Songqing Liu, Yunjia Liu, Pan Yu, Xuejun Sun · The FASEB Journal · 2014
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In rats, rats in the H₂ group displayed a reduced degree of myocardial neutrophilic infiltrate, necrosis, hemorrhage, and spindle‐shaped interstitial cells as compared with rats in the Control group..The number of TUNEL‐positive cells were increased in the myocardium in the Physiologic saline group and Control group. These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
What the Findings Mean
H2HUBB reviewed how molecular hydrogen affected the outcomes measured in rats. Rats in the H₂ group displayed a reduced degree of myocardial neutrophilic infiltrate, necrosis, hemorrhage, and spindle‐shaped interstitial cells as compared with rats in the Control group..The number of TUNEL‐positive cells were increased in the myocardium in the Physiologic saline group and Control group.
What the Researchers Studied
The researchers studied rats. The study used a preclinical animal experiment. The comparison condition was control condition or baseline measurements.
What Effects Did Molecular Hydrogen Have?
Reported treatment duration: 6 weeks. Rats in the H₂ group displayed a reduced degree of myocardial neutrophilic infiltrate, necrosis, hemorrhage, and spindle‐shaped interstitial cells as compared with rats in the Control group..The number of TUNEL‐positive cells were increased in the myocardium in the Physiologic saline group and Control group. The results of this study demonstrate that hydrogen‐rich saline ameliorated cardiotoxicity induced by Adriamycin by reducing oxidative stress and inflammatory cascades in heart tissue.
Why These Findings Matter
These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
How Strong Is This Evidence?
This is preclinical animal evidence from a preclinical animal experiment. It is most informative for the disease model, mechanisms, biomarkers, and outcomes directly measured in the study.
Technical Study Details
H2HUBB classifies this publication as animal study with preclinical animal evidence. The research population or model was rats. The reported sample size was 30. The study used a preclinical animal experiment. The reported treatment duration was 6 weeks.
Limitations and Safety
No separate limitations or safety findings were identified in the source text available to H2HUBB.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.